- Home
- APLM vs YHGJ Comparison
APLM vs YHGJ Comparison
Compare APLM & YHGJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- YHGJ
- Stock Information
- Founded
- APLM 2016
- YHGJ 1975
- Country
- APLM United States
- YHGJ United States
- Employees
- APLM N/A
- YHGJ N/A
- Industry
- APLM Blank Checks
- YHGJ Specialty Chemicals
- Sector
- APLM Finance
- YHGJ Industrials
- Exchange
- APLM Nasdaq
- YHGJ Nasdaq
- Market Cap
- APLM 12.3M
- YHGJ 14.0M
- IPO Year
- APLM N/A
- YHGJ 1997
- Fundamental
- Price
- APLM $9.56
- YHGJ $0.57
- Analyst Decision
- APLM Strong Buy
- YHGJ
- Analyst Count
- APLM 2
- YHGJ 0
- Target Price
- APLM $425.00
- YHGJ N/A
- AVG Volume (30 Days)
- APLM 36.2K
- YHGJ 24.2K
- Earning Date
- APLM 02-15-2025
- YHGJ 02-19-2025
- Dividend Yield
- APLM N/A
- YHGJ N/A
- EPS Growth
- APLM N/A
- YHGJ N/A
- EPS
- APLM N/A
- YHGJ N/A
- Revenue
- APLM $2,101,000.00
- YHGJ $18,559,000.00
- Revenue This Year
- APLM N/A
- YHGJ N/A
- Revenue Next Year
- APLM N/A
- YHGJ N/A
- P/E Ratio
- APLM N/A
- YHGJ N/A
- Revenue Growth
- APLM 70.54
- YHGJ 11.78
- 52 Week Low
- APLM $6.50
- YHGJ $0.43
- 52 Week High
- APLM $91.00
- YHGJ $1.85
- Technical
- Relative Strength Index (RSI)
- APLM 46.48
- YHGJ 47.71
- Support Level
- APLM $9.50
- YHGJ $0.52
- Resistance Level
- APLM $10.67
- YHGJ $0.62
- Average True Range (ATR)
- APLM 0.92
- YHGJ 0.08
- MACD
- APLM -0.04
- YHGJ 0.00
- Stochastic Oscillator
- APLM 13.17
- YHGJ 41.61
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About YHGJ Yunhong Green CTI Ltd.
Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.